Literature DB >> 2349597

Lidocaine accelerates neuroelectrical recovery after incomplete global ischemia in rabbits.

N Rasool1, M Faroqui, E H Rubinstein.   

Abstract

The use of high-dose lidocaine for cerebral protection during ischemia has produced varied results. Our study uses a new, single carotid artery preparation in the rabbit to produce incomplete global ischemia by graded carotid occlusion; specific electroencephalographic changes are used as the end point for the extent of blood flow reduction sustained during 20 minutes. We monitored arterial pressure, intracranial pressure, and internal carotid blood flow that were recorded with an electromagnetic flowmeter after surgical ligation of the opposite internal and the two vertebral arteries, and we studied the electroencephalogram and somatosensory-evoked potentials elicited by stimulation of the sciatic nerve. Low-dose lidocaine (0.2 mg/kg/min) infused throughout the experiment significantly accelerated the time course of the return of electroencephalographic and evoked-potential amplitudes toward control. Deep halothane anesthesia alone elicited the slowest recovery, suggesting that the action of lidocaine was independent of its general anesthetic effect. There were very small differences among the groups in the measured arterial pressure, intracranial pressure, and cerebral blood flow, suggesting that lidocaine changed recovery rate without markedly modifying any characteristic of the postischemic cerebral perfusion. The protective effect of lidocaine may be the result of a specific blockade of Na+ channels or a decrease in excitatory neurotransmitter release, either of which would cause a delay in the onset of the events that lead to neuronal damage during ischemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2349597     DOI: 10.1161/01.str.21.6.929

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Scutellarin blocks sodium current in freshly isolated mouse hippocampal CA1 neurons.

Authors:  Guangqin Zhang; Suhua Qiu; Heming Wei
Journal:  Neurochem Res       Date:  2011-02-22       Impact factor: 3.996

Review 2.  Effects of anesthesia on cerebral blood flow, metabolism, and neuroprotection.

Authors:  Andrew M Slupe; Jeffrey R Kirsch
Journal:  J Cereb Blood Flow Metab       Date:  2018-07-16       Impact factor: 6.200

3.  Neuroprotection after major cardiovascular surgery.

Authors:  Jose Torres; Koto Ishida
Journal:  Curr Treat Options Neurol       Date:  2015-07       Impact factor: 3.598

4.  Actions of the novel neuroprotective agent, lifarizine (RS-87476), on voltage-dependent sodium currents in the neuroblastoma cell line, N1E-115.

Authors:  J G McGivern; L Patmore; R D Sheridan
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

Review 5.  Neuroprotective effect of lidocaine: is there clinical potential?

Authors:  Tiandong Leng; Xiuren Gao; James P Dilger; Jun Lin
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-04-25

6.  Neuroprotective properties of lifarizine compared with those of other agents in a mouse model of focal cerebral ischaemia.

Authors:  C M Brown; C Calder; C Linton; C Small; B A Kenny; M Spedding; L Patmore
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

Review 7.  Lignocaine: neuro-protective or wishful thinking?

Authors:  Simon J Mitchell; Alan F Merry
Journal:  J Extra Corpor Technol       Date:  2009-03

Review 8.  Neuroprotective effects of intravenous anesthetics: a new critical perspective.

Authors:  Federico Bilotta; Elisabetta Stazi; Alexander Zlotnik; Shaun E Gruenbaum; Giovanni Rosa
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.